DE69729958D1 - Verbindungen mit antiviraler aktivität - Google Patents

Verbindungen mit antiviraler aktivität

Info

Publication number
DE69729958D1
DE69729958D1 DE69729958T DE69729958T DE69729958D1 DE 69729958 D1 DE69729958 D1 DE 69729958D1 DE 69729958 T DE69729958 T DE 69729958T DE 69729958 T DE69729958 T DE 69729958T DE 69729958 D1 DE69729958 D1 DE 69729958D1
Authority
DE
Germany
Prior art keywords
connections
antiviral activity
positions
hydroxyl groups
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69729958T
Other languages
English (en)
Other versions
DE69729958T2 (de
Inventor
Shuji Fujita
Masaaki Numata
Kazuo Suzuki
Shigeki Nunomura
Mamoru Sugimoto
Masaki Terada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissin Foods Holdings Co Ltd
Original Assignee
Nissin Food Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Food Products Co Ltd filed Critical Nissin Food Products Co Ltd
Application granted granted Critical
Publication of DE69729958D1 publication Critical patent/DE69729958D1/de
Publication of DE69729958T2 publication Critical patent/DE69729958T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69729958T 1996-05-16 1997-05-16 Verbindungen mit antiviraler aktivität Expired - Fee Related DE69729958T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12202596 1996-05-16
JP12202596 1996-05-16
PCT/JP1997/001654 WO1997043296A1 (fr) 1996-05-16 1997-05-16 Nouveaux composes a activite antivirale

Publications (2)

Publication Number Publication Date
DE69729958D1 true DE69729958D1 (de) 2004-08-26
DE69729958T2 DE69729958T2 (de) 2005-07-28

Family

ID=14825732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729958T Expired - Fee Related DE69729958T2 (de) 1996-05-16 1997-05-16 Verbindungen mit antiviraler aktivität

Country Status (8)

Country Link
US (3) US6337390B1 (de)
EP (1) EP0957107B1 (de)
JP (1) JP4099234B2 (de)
AT (1) ATE271560T1 (de)
AU (1) AU737680C (de)
CA (1) CA2255070C (de)
DE (1) DE69729958T2 (de)
WO (1) WO1997043296A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4099234B2 (ja) * 1996-05-16 2008-06-11 日清食品株式会社 抗ウイルス活性を有する新規化合物
WO1999043689A1 (fr) * 1998-02-27 1999-09-02 Meiji Milk Products Co., Ltd. Nouveaux derives de kdn et medicaments les contenant sous forme de principes actifs
CA2356306C (en) * 1999-01-15 2006-02-21 The Board Of Trustees Of The University Of Illinois Sulfated phosphatidylinositols, their preparation and use
AU2002342188A1 (en) * 2001-10-30 2003-06-23 Microbiotix, Inc. Methods and compositions for treating flavivirus-mediated disease
JP2008074720A (ja) * 2006-09-19 2008-04-03 Noguchi Inst Ｇｍ３糖鎖プローブ
AU2008242583B2 (en) 2007-04-23 2013-10-10 Alnylam Pharmaceuticals, Inc. Glycoconjugates of RNA interference agents
AU2008340354B2 (en) 2007-12-04 2014-04-17 Alnylam Pharmaceuticals, Inc. Folate-iRNA conjugates
AU2014277867B2 (en) * 2007-12-04 2016-11-03 Arbutus Biopharma Corporation Targeting lipids
EP4074344A1 (de) 2007-12-04 2022-10-19 Arbutus Biopharma Corporation Targeting von lipiden
EP3604533A1 (de) 2008-04-11 2020-02-05 Arbutus Biopharma Corporation Ortsspezifische abgabe von nukleinsäuren durch kombination von gerichteten liganden mit endosomolytischen komponenten
JP5327839B2 (ja) * 2008-06-09 2013-10-30 国立大学法人埼玉大学 シアル酸誘導体の製造方法とインフルエンザウィルス阻害剤としての利用
KR101797531B1 (ko) * 2009-07-07 2017-11-15 아데노비르 파마 에이비 유행성 각결막염의 치료 또는 예방에 유용한 신규한 항바이러스성 화합물
JOP20200092A1 (ar) 2014-11-10 2017-06-16 Alnylam Pharmaceuticals Inc تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها
CA2995863A1 (en) * 2015-08-19 2017-02-23 Ian C. Schoenhofen Treatment and prevention of neisseria gonorrhoeae infection using cmp-activated nonulosonate analog compounds
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
MX2021001056A (es) 2018-08-13 2021-04-12 Alnylam Pharmaceuticals Inc Composiciones de agente de acido ribonucleico bicatenario (arnbc) de virus de la hepatitis b (vhb) y metodos de uso de las mismas.
CA3234210A1 (en) * 2021-10-14 2023-04-20 Max ALLSWORTH Method for the synthesis of evoc probes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164798A (ja) 1983-03-09 1984-09-17 Rikagaku Kenkyusho シアル酸含有糖脂質誘導体
JPH064671B2 (ja) 1985-04-02 1994-01-19 メクト株式会社 シアル酸誘導体及びその製造方法
JPS62212335A (ja) 1986-03-14 1987-09-18 Mitsui Toatsu Chem Inc ２−アリ−ル−２−メチルプロピルエ−テル誘導体およびそれを有効成分として含有する殺虫剤
JPS6345223A (ja) 1986-04-04 1988-02-26 Ueno Seiyaku Oyo Kenkyusho:Kk ひと免疫不全ウイルス性疾患処置剤
JPS63264493A (ja) 1986-12-29 1988-11-01 Mect Corp 活性カルボニル基を持つシアル酸誘導体
JPS6452794A (en) 1987-05-29 1989-02-28 Kanto Ishi Pharma Co Ltd Sialic acid-containing thioglycerolipid derivative and production thereof
JPH01125394A (ja) 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
JPH02304025A (ja) 1989-05-18 1990-12-17 Tanabe Seiyaku Co Ltd 抗レトロウィルス薬
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JPH03246297A (ja) 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
JPH04136001A (ja) 1990-09-27 1992-05-11 Tanabe Seiyaku Co Ltd β―シクロデキストリン・スルホンアミド誘導体のポリ硫酸エステル及びその製法
CA2105345A1 (en) 1992-09-02 1994-03-03 Petrus B. Kruger Chemical compound
US5344417A (en) 1992-09-11 1994-09-06 Becton, Dickinson And Company Universal fitting for inoculation receptacles
JPH06256373A (ja) 1993-01-11 1994-09-13 Dainippon Ink & Chem Inc 硫酸化オリゴ糖配糖体アシル化物およびこれを有効成分とする抗ウイルス剤
JP3062906B2 (ja) * 1993-01-29 2000-07-12 丸金醤油株式会社 Ｎ−アセチルノイラミン酸ホモポリマーの硫酸エステル
US5663151A (en) 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
JPH09183789A (ja) 1995-10-31 1997-07-15 Sanwa Kagaku Kenkyusho Co Ltd 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
JP4099234B2 (ja) * 1996-05-16 2008-06-11 日清食品株式会社 抗ウイルス活性を有する新規化合物

Also Published As

Publication number Publication date
US20020077472A1 (en) 2002-06-20
CA2255070C (en) 2006-08-15
AU737680B2 (en) 2001-08-30
DE69729958T2 (de) 2005-07-28
AU2789597A (en) 1997-12-05
EP0957107B1 (de) 2004-07-21
JP4099234B2 (ja) 2008-06-11
US6541461B2 (en) 2003-04-01
US20030073664A1 (en) 2003-04-17
AU737680C (en) 2002-05-02
WO1997043296A1 (fr) 1997-11-20
EP0957107A1 (de) 1999-11-17
CA2255070A1 (en) 1997-11-20
EP0957107A4 (de) 1999-11-17
US6337390B1 (en) 2002-01-08
ATE271560T1 (de) 2004-08-15
US6835720B2 (en) 2004-12-28

Similar Documents

Publication Publication Date Title
DE69729958D1 (de) Verbindungen mit antiviraler aktivität
ES2122472T3 (es) Derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
KR950704341A (ko) 신규한 스핀고당 지질 및 그의 사용
DK118286A (da) Terapeutisk aktive nucleosider, deres anvendelse og farmaceutiske kompositioner indeholdende forbindelserne
FI20001231A (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
BRPI9809791B8 (pt) compostos imuno efetores de fosfato de aminoalquil glucosamina e composições compreendendo os mesmos
DE69832375D1 (de) Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach-medikamentresistenz in krebs- und anderen zellen
DK15689A (da) Sukkerethere som blegestabile renseevneforstaerkere.
DE69024104D1 (de) Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase
DK0930077T3 (da) Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
FI860018A (fi) Laekemedelspreparat med reducerad toxisitet.
KR940021067A (ko) 에너지 보충 당류원 및 그 용도
ES2065980T3 (es) Uso del acido 5-aminosalicilico en el tratamiento de alteraciones dermatologicas.
ATE79034T1 (de) Behandlung von viruskrankheiten.
ATE90685T1 (de) Disaccharidderivate.
SE8704849D0 (sv) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
CA2041380A1 (en) Use of protein c or activated protein c for preparing a pharmaceutical preparation
EP0375610A3 (de) Perfluoralkylthioglykoside
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
IT1209519B (it) Composti ad attivita'cardiotrofica.
KR920700653A (ko) Hiv 활성을 저해하는데 공력작용을 하는 뉴클레오시드 유도체 복합물.
IT1197892B (it) Composizioni farmaceutiche ad attivita' cicatrizzante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NISSIN FOODS HOLDINGS CO., LTD., OSAKA, JP

8339 Ceased/non-payment of the annual fee